SCHEMBL1138482

SCHEMBL1138482

OB(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV6 Q9H1D0 6/20 0.80
ORAI1 Q96D31 5/20 0.80
ORAI2 Q96SN7 5/20 0.80
ORAI3 Q9BRQ5 5/20 0.80
ENPP2 Q13822 1/20 0.68
LMNA P02545 1/20 0.50
CYP2A6 P11509 1/20 0.50
PCSK9 Q8NBP7 1/20 0.50
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
IDO1 P14902 1/20 0.38
TSHR P16473 3/20 0.38
MAPK1 P28482 2/20 0.38
ALOX15 P16050 1/20 0.38
CYP3A4 P08684 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4833078 0.87 TRPV6 (0.76) TRPV6ORAI1ORAI2ORAI3ENPP2
SCHEMBL23219857 0.83 TRPV6 (0.79) TRPV6ORAI1ORAI2ORAI3ENPP2
SCHEMBL1138541 0.82 ORAI1 (0.57) TRPV6ORAI1ORAI2ORAI3ENPP2
SCHEMBL28166 0.81 ENPP2 (1.00) TRPV6ORAI1ORAI2ORAI3ENPP2
SCHEMBL19712647 0.80 ENPP2 (0.59) TRPV6ORAI1ORAI2ORAI3ENPP2
SCHEMBL28117303 0.79 ENPP2 (0.94) TRPV6ORAI1ORAI2ORAI3ENPP2
SCHEMBL27648777 0.79 ENPP2 (0.94) TRPV6ORAI1ORAI2ORAI3ENPP2
SCHEMBL4827542 0.77 TRPV6 (0.62) TRPV6ORAI1ORAI2ORAI3ENPP2
SCHEMBL17655876 0.77 ENPP2 (0.62) TRPV6ORAI1ORAI2ORAI3ENPP2
SCHEMBL1138563 0.77 ENPP2 (0.62) TRPV6ORAI1ORAI2ORAI3ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230340530-A1 Methods of Protecting RNA PFIZER INC. (US) 2023-10-26 US claimed
EP-4204012-A1 METHODS OF PROTECTING RNA Pfizer Inc. (US) 2023-07-05 EP claimed
US-9868694-B2 Process for preparing chlorinated biphenylanilides and biphenylanilines BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-01-16 US claimed
EP-1856024-B2 METHOD FOR PRODUCING SUBSTITUTED BIPHENYLS BASF SE (DE) 2011-08-17 EP claimed
US-7772446-B2 Method for producing substituted biphenyls BASF SE (DE) 2010-08-10 US claimed
US-20090082561-A1 Methods For The Preparation Of Alkyl Diaryl Borinates And Complexed Diarylboronic Acids THE PENNSYLVANIA STATE RESEARCH FOUNDATION 2009-03-26 US claimed
EP-1856024-B1 METHOD FOR PRODUCING SUBSTITUTED BIPHENYLS BASF SE (DE) 2008-08-06 EP claimed
US-20080183021-A1 Method for Producing Substituted Biphenyls BASF SE (DE) 2008-07-31 US claimed
EP-1856024-A1 METHOD FOR PRODUCING SUBSTITUTED BIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2007-11-21 EP claimed
WO-2006092429-A1 METHOD FOR PRODUCING SUBSTITUTED BIPHENYLS BASF AKTIENGESELLSCAHFT (DE) 2006-09-08 WO claimed
US-20050080048-A1 Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids PENN STATE RESEARCH FOUNDATION, THE 2005-04-14 US claimed
EP-1463739-A2 METHODS FOR THE PREPARATION OF ALKYL DIARYL BORINATES AND COMPLEXED DIARYLBORINIC ACIDS THE PENNSYLVANIA STATE RESEARCH FOUNDATION (US) 2004-10-06 EP claimed
US-6600066-B1 Process for preparing perhalogenated monoorganoboranes or diorganoboranes which makes it possible to obtain these compounds under conditions which can readily be implemented in the industry is described. BASELL POLYOLEFINE GMBH (DE) 2003-07-29 US claimed
WO-2003059916-A2 METHODS FOR THE PREPARATION OF ALKYL DIARYL BORINATES AND COMPLEXED DIARYLBORINIC ACIDS THE PENNSYLVANIA STATE RESEARCH FOUNDATION (US) 2003-07-24 WO claimed
EP-1140947-B1 METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES BASELL POLYOLEFINE GMBH (DE) 2003-03-12 EP claimed
EP-1140947-A1 METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES Basell Polyolefine GmbH (DE) 2001-10-10 EP claimed
WO-2000037476-A1 METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES BASELL POLYOLEFINE GMBH (DE) 2000-06-29 WO claimed
US-20230340530-A1 Methods of Protecting RNA PFIZER INC. (US) 2023-10-26 US disclosed
EP-1003753-A1 COMPOUNDS CONTAINING BORON AND ALUMINIUM Basell Polyolefine GmbH (DE) 2000-05-31 EP disclosed
WO-1999006414-A1 COMPOUNDS CONTAINING BORON AND ALUMINIUM TARGOR GMBH (DE) 1999-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082561-A1 Methods For The Preparation Of Alkyl Diaryl Borinates And Complexed Diarylboronic Acids BCL6B, BLVRB, SSB TRPV6 1769/4885ORAI1 1065/4885ORAI2 874/4885
US-20050080048-A1 Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids BCL6B, BLVRB, SSB TRPV6 1769/4885ORAI1 1065/4885ORAI2 874/4885
US-20080183021-A1 Method for Producing Substituted Biphenyls CBR3, DDT, HRH3 TRPV6 1463/4885ORAI1 4349/4885ORAI2 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.